Incus Pharmaceuticals Private Limited, a active private limited company, was established on 21 October 2009 in Kochi, Kerala, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U51397KL2009PTC024907. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.51 M and a paid-up capital of ₹0.51 M.
It upholds a compliant status. Its leadership includes Thulaseedharan Pillai Suresh Kumar (Whole-Time Director), Narayanan Priyaranjan Das (Managing Director), Babu Philip (Whole-Time Director). Past directors included Thulaseedharan Pillai Suresh Kumar, Babu Philip, Plammoottil Janardhanan Pillai Abhilash. It holds ₹6.73 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 51-1468, Akg Road, Thykodam Vyttila, Kochi, Kerala, 682019.
U51397KL2009PTC024907
024907
21 October 2009
₹0.51 M
₹0.51 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Incus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thulaseedharan Pillai Suresh Kumar | Whole-Time Director | 21 Oct 2009 | Current |
| Narayanan Priyaranjan Das | Managing Director | 21 Oct 2009 | Current |
| Babu Philip | Whole-Time Director | 21 Oct 2009 | Current |
| Plammoottil Janardhanan Pillai Abhilash | Director | 08 Dec 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Feb 2016 | Past |
| Pramod Abcsdd | Director | 29 Feb 2016 | Past |
| Pramod Abcsdd | Director | 29 Feb 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Incus Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Incus Pharmaceuticals had a public holding of 7.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,728,838.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Apr 2025 | Others | ₹1.38 M | Open |
| 03 Mar 2025 | Bank Of India | ₹0.79 M | Open |
| 08 May 2024 | Bank Of India | ₹1.03 M | Open |
| 27 Jun 2022 | Hdfc Bank Limited | ₹0.73 M | Open |
| 17 Oct 2019 | State Bank Of India | ₹2.80 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Incus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Incus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 1.38 M with Charge ID 101116207 was registered on 08 Apr 2025. was completed.
The activity A charge with State Bank Of India of Rs. 2.80 M registered on 17 Oct 2019 with Charge ID 100299576 was modified on 07 Apr 2025. was completed.
A charge with Bank Of India amounted to Rs. 0.79 M with Charge ID 101063661 was registered on 03 Mar 2025. was recorded as a recent event.
Progress on Incus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Bank Of India amounted to Rs. 1.03 M with Charge ID 100928370 was registered on 08 May 2024. was documented.
The activity Incus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was completed.
The CIN of Incus Pharmaceuticals Private Limited is U51397KL2009PTC024907.
Incus Pharmaceuticals Private Limited is headquartered at 51-1468, Akg Road, Thykodam Vyttila, Kochi, Kerala, 682019.
Incus Pharmaceuticals Private Limited was incorporated on 21 October 2009.
The current directors of Incus Pharmaceuticals Private Limited are
The primary industry of Incus Pharmaceuticals Private Limited is Professional, Scientific And Technical.
Incus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Incus Pharmaceuticals Private Limited is ₹0.51 M, and the paid-up capital is ₹0.51 M.
The compliance status of Incus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX